# REal-Life Cohort With DOlutegravir + LAmivudina

> **NCT04638686** · — · COMPLETED · sponsor: **Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz** · enrollment: 185 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Dolutegravir 50 MG
- **DRUG:** Lamivudine 300 MG

## Key facts

- **NCT ID:** NCT04638686
- **Lead sponsor:** Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2021-06-15
- **Final completion:** 2022-03-31
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04638686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04638686, "REal-Life Cohort With DOlutegravir + LAmivudina". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04638686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*